Novo Nordisk

Novo Nordisk is a global healthcare company based in Denmark, specializing in diabetes care and hormone replacement therapies. Founded in 1923, it is known for developing insulin products that help manage diabetes, a condition affecting millions worldwide. The company also produces treatments for obesity, hemophilia, and other chronic diseases. Novo Nordisk emphasizes innovation and sustainability, focusing on improving patient outcomes and expanding access to care. With a commitment to research and development, it remains a leader in the biopharmaceutical industry, balancing business success with social responsibility.